The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Neuroprotective, Anti-Amyloidogenic and Neurotrophic Effects of Apigenin in an Alzheimer’s Disease Mouse Model
Open accessAbstract
Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by extracellular senile plaques and intracellular neurofibrillary tangles in the brain. Amyloid-β peptides (Aβ) are considered to play a critical role in the onset and progression of AD. Apigenin (4',5,7-trihydroxyflavone) is a pharmacologically active agent. Even though some evidence suggests that it has potential neuroprotective effects, no preexisting study has reported any therapeutic effects of apigenin in AD models. In the present study, we examined the effects of apigenin on cognitive function in APP/PS1 double transgenic AD mice and explored its mechanism(s) of action. Three-month oral treatment with apigenin rescued learning deficits and relieved memory retention in APP/PS1 mice. Apigenin also showed effects affecting APP processing and preventing Aβ burden due to the down-regulation of BACE1 and β-CTF levels, the relief of Aβ deposition, and the decrease of insoluble Aβ levels. Moreover, apigenin exhibited superoxide anion scavenging effects and improved antioxidative enzyme activity of superoxide dismutase and glutathione peroxidase. In addition, apigenin restored neurotrophic ERK/CREB/BDNF pathway in the cerebral cortex. In conclusion, apigenin may ameliorate AD-associated learning and memory impairment through relieving Aβ burden, suppressing amyloidogenic process, inhibiting oxidative stress, and restoring ERK/CREB/BDNF pathway. Therefore, apigenin appears to represent an alternative medication for the prevention and/or therapy of AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Pathways towards and Away from Alzheimer’s Disease
Mattson, M. P. (2004) · Nature · doi:10.1038/nature02621 · Cited by 3,052
Oxidative stress hypothesis in Alzheimer’s disease
Markesbery, W. R. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00629-6 · Cited by 2,383
Hydrogen peroxide mediates amyloid β protein toxicity
Behl, C. (1994) · Cell · doi:10.1016/0092-8674(94)90131-7 · Cited by 2,074
Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease
Lue, L.-F., Kuo, Y.-M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. H., Rydel, R. E., & Rogers, J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65184-x · Cited by 1,530
Oxidative damage in Alzheimer's
Smith, M. A., Perry, G., Richey, P. L., Sayrec, L. M., Anderson, V. E., Beal, M. F., & Kowall, N. (1996) · Nature · doi:10.1038/382120b0 · Cited by 894
Normal and Abnormal Biology of the beta-Amyloid Precursor Protein
Selkoe, D. J. (1994) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.17.030194.002421 · Cited by 818
Praticò, D., Uryu, K., Leight, S., Trojanoswki, J. Q., & Lee, V. M.-Y. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-12-04183.2001 · Cited by 777
Co-expression of multiple transgenes in mouse CNS: a comparison of strategies
Jankowsky, J. L., Slunt, H. H., Ratovitski, T., Jenkins, N. A., Copeland, N. G., & Borchelt, D. R. (2001) · Biomolecular Engineering · doi:10.1016/s1389-0344(01)00067-3 · Cited by 746
A learning deficit related to age and β-amyloid plaques in a mouse model of Alzheimer's disease
Chen, G., Chen, K. S., Knox, J., Inglis, J., Bernard, A., Martin, S. J., Justice, A., McConlogue, L., Games, D., Freedman, S. B., et al. (2000) · Nature · doi:10.1038/35050103 · Cited by 740
Heldt, S. A., Stanek, L., Chhatwal, J. P., & Ressler, K. J. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001957 · Cited by 684
Tyler, W. J., Alonso, M., Bramham, C. R., & Pozzo-Miller, L. D. (2002) · Learning & Memory · doi:10.1101/lm.51202 · Cited by 682
Ono, K., Yoshiike, Y., Takashima, A., Hasegawa, K., Naiki, H., & Yamada, M. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01976.x · Cited by 681
Lovell, M. A., Ehmann, W. D., Butler, S. M., & Markesbery, W. R. (1995) · Neurology · doi:10.1212/wnl.45.8.1594 · Cited by 644
Bekinschtein, P., Cammarota, M., Igaz, L. M., Bevilaqua, L. R. M., Izquierdo, I., & Medina, J. H. (2007) · Neuron · doi:10.1016/j.neuron.2006.11.025 · Cited by 633
β-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding
Busciglio, J., Lorenzo, A., Yeh, J., & Yankner, B. A. (1995) · Neuron · doi:10.1016/0896-6273(95)90232-5 · Cited by 595
He, P., Zhong, Z., Lindholm, K., Berning, L., Lee, W., Lemere, C., Staufenbiel, M., Li, R., & Shen, Y. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200705042 · Cited by 390
Anderson, A., Su, J., & Cotman, C. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-05-01710.1996 · Cited by 389
Progressive age‐related development of Alzheimer‐like pathology in APP/PS1 mice
Trinchese, F., Liu, S., Battaglia, F., Walter, S., Mathews, P. M., & Arancio, O. (2004) · Annals of Neurology · doi:10.1002/ana.20101 · Cited by 373
Blanchard, V., Moussaoui, S., Czech, C., Touchet, N., Bonici, B., Planche, M., Canton, T., Jedidi, I., Gohin, M., Wirths, O., et al. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00252-8 · Cited by 283
Ding, Y., Qiao, A., Wang, Z., Goodwin, J. S., Lee, E.-S., Block, M. L., Allsbrook, M., McDonald, M. P., & Fan, G.-H. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3153-08.2008 · Cited by 269
β-Amyloid protein-induced Alzheimer's disease animal model
Nitta, A., Itoh, A., Hasegawa, T., & Nabeshima, T. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90239-9 · Cited by 266
Cole, S. L., & Vassar, R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800015200 · Cited by 262
Park, L., Anrather, J., Zhou, P., Frys, K., Pitstick, R., Younkin, S., Carlson, G. A., & Iadecola, C. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.5207-04.2005 · Cited by 244
Shimmyo, Y., Kihara, T., Akaike, A., Niidome, T., & Sugimoto, H. (2008) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.01.017 · Cited by 234
Lipid peroxidation and oxidative imbalance: early functional events in Alzheimer's disease
Praticò, D., & Sung, S. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6209 · Cited by 229 · cited 1×
“Oxidative damage is often postulated to be an preceeding event in AD pathogenesis [38,39].”
BackgroundTong, L., Balazs, R., Thornton, P. L., & Cotman, C. W. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.5463-03.2004 · Cited by 221
Tong, L., Thornton, P. L., Balazs, R., & Cotman, C. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010450200 · Cited by 206
Molecular Enhancement of Memory Formation
Carew, T. J. (1996) · Neuron · doi:10.1016/s0896-6273(00)80016-1 · Cited by 202
CREB, memory enhancement and the treatment of memory disorders: promises, pitfalls and prospects
Barco, A., Pittenger, C., & Kandel, E. R. (2003) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.7.1.101 · Cited by 201
Wang, C.-N., Chi, C.-W., Lin, Y.-L., Chen, C.-F., & Shiao, Y.-J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006406200 · Cited by 181
Pham, T. A., Impey, S., Storm, D. R., & Stryker, M. P. (1999) · Neuron · doi:10.1016/s0896-6273(00)80679-0 · Cited by 173
Kar, S., Issa, A. M., Seto, D., Auld, D. S., Collier, B., & Quirion, R. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70052179.x · Cited by 167
Novel Neuronal Phenotypes from Neural Progenitor Cells
Markakis, E. A., Palmer, T. D., Randolph‐Moore, L., RAKIC, P. T., & Gage, F. H. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.4161-03.2004 · Cited by 152
Hou, Y., Aboukhatwa, M. A., Lei, D.-L., Manaye, K. F., Khan, I. A., & Luo, Y. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.11.002 · Cited by 143
Zhao, L., Wang, J., Wang, Y.-R., & Fa, X.-Z. (2012) · Brain Research · doi:10.1016/j.brainres.2012.11.019 · Cited by 140
Self-citationVasodilatory action mechanisms of apigenin isolated from Apium graveolens in rat thoracic aorta
Ko, F., Huang, T., & Teng, C. (1991) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(91)90013-7 · Cited by 126
Anti-Influenza Virus Activities of Flavonoids from the Medicinal PlantElsholtzia rugulosa
Liu, A., Liu, B., Qin, H., Lee, S. M., Wang, Y., & Du, G. (2008) · Planta Medica · doi:10.1055/s-2008-1074558 · Cited by 124
Patil, C. S., Singh, V. P., Satyanarayan, P. S. V., Jain, N., Singh, À., & Kulkarni, S. K. (2003) · Pharmacology · doi:10.1159/000072357 · Cited by 124
Özyürek, M., Bektaşoğlu, B., Güçlü, K., & Apak, R. (2009) · Analytica Chimica Acta · doi:10.1016/j.aca.2009.01.037 · Cited by 120
Liu, R., Zhang, T., Yang, H., Lan, X., Ying, J., & Du, G. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101593 · Cited by 115
Self-citationProtection of Apigenin against Kainate-Induced Excitotoxicity by Anti-oxidative Effects
Han, J., Ahn, S., Kim, C.-S., Yoo, S.-K., Kim, S., Kim, H., Hong, J. T., & Oh, K. (2012) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b110686 · Cited by 102
Apigenin modulates GABAergic and glutamatergic transmission in cultured cortical neurons
Losi, G., Puia, G., Garzon, G., Vuono, M. C. D., & Baraldi, M. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.08.043 · Cited by 100
Wang, Y.-C., & Huang, K.-M. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.12.018 · Cited by 99
Sigurdsson, E. M., Lee, J. M., Dong, X.-W., Hejna, M. J., & Lorens, S. A. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00154-1 · Cited by 83
Peng, Y., Hu, Y., Xu, S., Li, P., Jiang, L., Lu, L., Yang, H., Feng, N., Wang, L., & Wang, X. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-111577 · Cited by 63
The Role of Neurotrophins in Brain Aging: A Perspective in Honor of Regino Perez-Polo
Cotman, C. W. (2005) · Neurochemical Research · doi:10.1007/s11064-005-6960-y · Cited by 62
Amyloid-β Production Via Cleavage of Amyloid-β Protein Precursor is Modulated by Cell Density
Zhang, C. M., Browne, A., DiVito, J. R., Stevenson, J. A., Romano, D., Dong, Y., Xie, Z., & Tanzi, R. E. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100816 · Cited by 54
Liu, R., Zhang, T., Zhou, D., Bai, X., Zhou, W., Huang, C., Song, J.-K., Meng, F.-R., Wu, C., Li, L., et al. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.11.018 · Cited by 54
Self-citationRithidech, K. N., Tungjai, M., Reungpatthanaphong, P., Honikel, L., & Simon, S. R. (2012) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2012.08.001 · Cited by 53
Amini, R., Yazdanparast, R., & Bahramikia, S. (2013) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2013.06.013 · Cited by 37
Zhao, L., Hou, L., Sun, H., Yan, X., Sun, X., Li, J., Bian, Y., Chu, Y., & Liu, Q. (2011) · Molecules · doi:10.3390/molecules16054005 · Cited by 33
Self-citationMiners, J. S., Morris, S., Love, S., & Kehoe, P. G. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101395 · Cited by 31
Lee, S., Zemianek, J. M., & Shea, T. B. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122452 · Cited by 24
Cited by
The Therapeutic Potential of Apigenin
Salehi, B., Venditti, A., Sharifi-Rad, M., Kręgiel, D., Sharifi-Rad, J., Durazzo, A., Lucarini, M., Santini, A., Souto, E. B., Novellino, E., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061305 · Cited by 1,238
Health functionality of apigenin: A review
Ali, F., Rahul, Naz, F., Jyoti, S., & Siddique, Y. H. (2017) · International Journal of Food Properties · doi:10.1080/10942912.2016.1207188 · Cited by 343
Balez, R., Steiner, N., Engel, M., Muñoz, S. S., Lum, J. S., Wu, Y., Wang, D., Vallotton, P., Sachdev, P., O’Connor, M., et al. (2016) · Scientific Reports · doi:10.1038/srep31450 · Cited by 278
Flavonoid-Based Therapies in the Early Management of Neurodegenerative Diseases
Solanki, I., Parihar, P., Mansuri, M. L., & Parihar, M. S. (2015) · Advances in Nutrition · doi:10.3945/an.114.007500 · Cited by 267
Andrade, S., Ramalho, M. J., Loureiro, J. A., & Pereira, M. D. C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092313 · Cited by 240
Metadata
- Authors
- Zhao, L., Wang, J.-L., Liu, R., Li, X.-X., Li, J.-F., & Zhang, L.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2013-08-19
- Volume
- 18
- Issue
- 8
- Pages
- 9949-9965
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W2093456557
- Cited by
- 311
- References
- 54
- FWCI
- 5.71
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.